Loading...
APEN logo

Apollo Endosurgery, Inc.NasdaqGM:APEN Stock Report

Market Cap US$579.7m
Share Price
n/a
My Fair Value
n/a
1Y67.8%
7D0.8%
Portfolio Value
​
View

Apollo Endosurgery, Inc.

NasdaqGM:APEN Stock Report

Market Cap: US$579.7m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Apollo Endosurgery (APEN) Stock Overview

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices for gastrointestinal therapeutic endoscopy. More details

APEN fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Rewards

Revenue is forecast to grow 32.05% per year

Risk Analysis

Shareholders have been diluted in the past year

Currently unprofitable and not forecast to become profitable over the next 3 years


APEN Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

Apollo Endosurgery, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Apollo Endosurgery
Historical stock prices
Current Share PriceUS$10.00
52 Week HighUS$10.30
52 Week LowUS$3.49
Beta2.32
1 Month Change0.50%
3 Month Change1.11%
1 Year Change67.79%
3 Year Change360.83%
5 Year Change70.94%
Change since IPO-17.76%

Recent News & Updates

Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?

Apr 03
Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?

Is Apollo Endosurgery (NASDAQ:APEN) Weighed On By Its Debt Load?

Nov 30
Is Apollo Endosurgery (NASDAQ:APEN) Weighed On By Its Debt Load?

Recent updates

Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?

Apr 03
Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?

Is Apollo Endosurgery (NASDAQ:APEN) Weighed On By Its Debt Load?

Nov 30
Is Apollo Endosurgery (NASDAQ:APEN) Weighed On By Its Debt Load?

Is Apollo Endosurgery (NASDAQ:APEN) Using Too Much Debt?

Aug 05
Is Apollo Endosurgery (NASDAQ:APEN) Using Too Much Debt?

Apollo Endosurgery: Collect Shares At A Discount Following Q2 Earnings

Aug 04

Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?

Mar 02
Is Apollo Endosurgery (NASDAQ:APEN) Using Debt Sensibly?

Is Apollo Endosurgery, Inc. (NASDAQ:APEN) Trading At A 20% Discount?

Aug 04
Is Apollo Endosurgery, Inc. (NASDAQ:APEN) Trading At A 20% Discount?

Apollo Endosurgery: New Management Bounce Makes Weight Loss Specialist A Buy

Jun 28

Is Apollo Endosurgery (NASDAQ:APEN) A Risky Investment?

May 05
Is Apollo Endosurgery (NASDAQ:APEN) A Risky Investment?

A Look At The Intrinsic Value Of Apollo Endosurgery, Inc. (NASDAQ:APEN)

Mar 24
A Look At The Intrinsic Value Of Apollo Endosurgery, Inc. (NASDAQ:APEN)

What Percentage Of Apollo Endosurgery, Inc. (NASDAQ:APEN) Shares Do Insiders Own?

Mar 03
What Percentage Of Apollo Endosurgery, Inc. (NASDAQ:APEN) Shares Do Insiders Own?

Trade Alert: Neil Gagnon At Apollo Endosurgery, Inc. (NASDAQ:APEN), Has Just Spent US$146k Buying 2.8% More Shares

Feb 10
Trade Alert: Neil Gagnon At Apollo Endosurgery, Inc. (NASDAQ:APEN), Has Just Spent US$146k Buying 2.8% More Shares

We Think Apollo Endosurgery (NASDAQ:APEN) Has A Fair Chunk Of Debt

Jan 31
We Think Apollo Endosurgery (NASDAQ:APEN) Has A Fair Chunk Of Debt

If You Had Bought Apollo Endosurgery's (NASDAQ:APEN) Shares Three Years Ago You Would Be Down 36%

Dec 27
If You Had Bought Apollo Endosurgery's (NASDAQ:APEN) Shares Three Years Ago You Would Be Down 36%

Is It Too Late To Consider Buying Apollo Endosurgery, Inc. (NASDAQ:APEN)?

Dec 01
Is It Too Late To Consider Buying Apollo Endosurgery, Inc. (NASDAQ:APEN)?

Shareholder Returns

APENUS Medical EquipmentUS Market
7D0.8%0.1%3.3%
1Y67.8%-8.5%28.1%

Return vs Industry: APEN exceeded the US Medical Equipment industry which returned -13.3% over the past year.

Return vs Market: APEN exceeded the US Market which returned -11.4% over the past year.

Price Volatility

Is APEN's price volatile compared to industry and market?
APEN volatility
APEN Average Weekly Movement0.5%
Medical Equipment Industry Average Movement8.0%
Market Average Movement7.1%
10% most volatile stocks in US Market16.1%
10% least volatile stocks in US Market3.3%

Stable Share Price: APEN has not had significant price volatility in the past 3 months.

Volatility Over Time: APEN's weekly volatility has decreased from 12% to 1% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2005202Chas McKhannwww.apolloendo.com

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices for gastrointestinal therapeutic endoscopy. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to suture and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying, which assists the patient in losing weight under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands.

Apollo Endosurgery, Inc. Fundamentals Summary

How do Apollo Endosurgery's earnings and revenue compare to its market cap?
APEN fundamental statistics
Market capUS$579.72m
Earnings (TTM)-US$39.84m
Revenue (TTM)US$76.86m
7.5x
P/S Ratio
-14.6x
P/E Ratio

Is APEN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
APEN income statement (TTM)
RevenueUS$76.86m
Cost of RevenueUS$34.43m
Gross ProfitUS$42.43m
Other ExpensesUS$82.27m
Earnings-US$39.84m

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.69
Gross Margin55.20%
Net Profit Margin-51.84%
Debt/Equity Ratio164.7%

How did APEN perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/04/06 01:23
End of Day Share Price 2023/04/03 00:00
Earnings2022/12/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Apollo Endosurgery, Inc. is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew HewittCraig-Hallum Capital Group LLC
Frank TakkinenLake Street Capital Markets, LLC
Suraj KaliaNorthland Capital Markets